HHS Secretary Alex Azar declares a public health emergency in California over ongoing wildfires; a new formulary from Express Scripts will encourage drug makers to move away from paying rebates and instead keep list prices low; part of Oscar Health’s expansion efforts has brought the insurer to Florida, but the company has said its efforts are being “stymied” by Florida Blue.
The wildfires in California have caused HHS Secretary Alex Azar to declare a public health emergency, which gives CMS beneficiaries and their providers greater flexibility to meet health needs resulting from the wildfires. Two hospitals and 8 healthcare facilities have been evacuated, and a smoke advisory has been issued for portions of Los Angeles County. People with lung conditions are faced with significant health threats. HHS has also deployed regional emergency coordinators to serve as HHS’ primary representatives for emergency response and recovery.
A new formulary from Express Scripts will encourage drug makers to move away from paying rebates and instead keep list prices low. Reuters reported that the new National Preferred Flex Formulary will be available starting January 1. The formulary will streamline the introduction of authorized alternatives to branded drugs and reduce reliance on branded products, according to Express Scripts. The new list is largely similar to the pharmacy benefit manager’s National Preferred Formulary.
Part of Oscar Health’s expansion efforts has brought the insurer to Florida, but the company has said its efforts are being “stymied” by Florida Blue, according to Forbes. Oscar has sued Florida Blue, accusing it of working as a monopoly by preventing brokers from doing business with other health plans. Oscar is seeking to end Florida Blue’s “exclusive broker policy.” Florida Blue, which covers more than 1 million customers in the Affordable Care Act marketplace alone, said Oscar’s suit has no merit.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More